Stock Price Forecast for ARDX: The Ardelyx stock holds several negative signals and despite the positive trend we believe Ardelyx will perform weak in the next Mar 9, 2020 Ardelyx (ARDX) Received its Third Buy in a Row Analyst Chris Shibutani maintained a Buy rating on Ardelyx today. Share on StockTwits. Sep 17, 2019 Ardelyx's long-gestating challenger tenapanor received an FDA approval of its own Thursday under the brand name Ibsrela. Back in 2018 Oct 31, 2019 Ardelyx actively is seeking a partner to market it in the U.S. For Ibsrela's full prescribing information, look here. New Ofev Indication. A new FDA Follow Us! StockTwits Twitter · ETF Daily News. Toggle navigation. Toggle navigation SNBR · SLEEP NUMBER CORP, 0.00%. ARDX · ARDELYX INC, 0.00%. Follow Us! StockTwits Twitter · ETF Daily News. Toggle navigation. Toggle navigation BRBR · BellRing Brands Inc. Class A, 0.00%. ARDX · Ardelyx Inc. 0.00%. 7/39, 103, -, 8.82 | 2.10, Ardelyx Inc. ARDX, 7.33, -6.7, 6.94 - 8.33, 32932. Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has 1/1, 130
Ardelyx, Inc. Biotechnology Fremont, CA 3,550 followers Passionately committed to bettering the lives of patients with kidney and cardiovascular diseases.
Ardelyx earned a coverage optimism score of -3.8 on InfoTrie's scale. They also gave press coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. ARDX Stock News - Fidelity
Ardelyx serves patients in the United States. Address. 34175 Ardenwood Blvd Suite 200 Fremont, CA 94555 United States. Phone. 1-510-745-1700. Website www.ardelyx.com. Executives. Name/Title.
Ardelyx serves patients in the United States. Address. 34175 Ardenwood Blvd Suite 200 Fremont, CA 94555 United States. Phone. 1-510-745-1700. Website www.ardelyx.com. Executives. Name/Title. Here's Why Tiny Biotech Ardelyx Saw a ... - The Motley Fool Here's Why Tiny Biotech Ardelyx Saw a Big Decline Today The stock is down almost 20% after the company announced it was raising cash two different ways. Ardelyx | Crunchbase Ardelyx develops novel, first-in-class oral therapeutics to correct mineral metabolism and metabolic disorders. The Company's molecules, whose systemic exposure is severely restricted, target transporters and receptors, modulating the uptake of nutrients or inducing secretion of key hormones to produce a therapeutic benefit in patients.
Description: Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform.
ARDX Ardelyx, Inc. Stock Quote - FINVIZ.com It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California. Ardelyx, Inc. (ARDX) Stock Message Board - InvestorsHub
ARDX: Ardelyx Inc - Zacks Investment Research
ARDX Stock Price & Charts | Ardelyx
- schwab td ameritrade财务顾问